Navigating efficacy testing for skincare products: A strategic imperative for the US market
In a US market where scientific validation increasingly shapes both regulatory expectations and consumer behaviour, efficacy testing has evolved from a compliance task into a decisive competitive lever. With performance-driven claims now influencing purchasing more strongly than “clean” or “natural” positioning, brands must demonstrate not only that formulations are safe, but that they deliver quantifiable, reproducible effects.
Today’s US consumers expect substantiated multifunctionality: hydration kinetics, barrier optimisation, biome-friendly action, pigmentation control, and clinically measurable anti-ageing effects. As the mechanisms behind these insights advance, so too does scrutiny of study design, from population relevance to endpoint robustness and statistical power.
Effective strategies begin with scientific alignment.
- Define precise claims based on ingredient functionality, mode of action and regulatory constraints.
- Integrate testing early, mapping timelines around stability, safety (e.g., HRIPT, SIU) and multi-phase efficacy programmes.
- Select the right methodologies: high-resolution imaging, biophysical instrumentation, longitudinal clinical scoring and targeted microbiome or biomarker analyses provide complementary evidence.
In a market that increasingly values transparency, efficacy is not merely a requirement — it is a growth strategy. Those who master evidence-based narratives will secure consumer trust and long-term relevance.
At Eurofins Cosmetics & Personal Care, our global expertise supports brands from claim ideation to compliant substantiation, delivering rigorous, market-aligned data packages. By transforming technical evidence into credible claims, we help position performance as a true driver of brand differentiation.
Find out more: Download the full white paper here